BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Blueprint Medicines 



Cambridge  Massachusetts  02140  U.S.A.
Phone: 617-585-2033 Fax: n/a


SEARCH JOBS




Industry
Biotechnology






 Company News
First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 9/19/2014 10:31:29 AM
First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 9/19/2014 8:02:57 AM
Blueprint Medicines Discovers Novel Cancer Drug Targets 9/10/2014 9:56:28 AM
Blueprint Medicines To Participate In Morgan Stanley (MST) Global Healthcare Conference 2014 9/9/2014 8:50:15 AM
Blueprint Medicines Presents Positive Data On BLU-554 For Hepatocellular Carcinoma 9/8/2014 9:10:23 AM
Blueprint Medicines To Present At Wedbush 2014 Life Sciences Management Access Conference 8/6/2014 8:48:59 AM
Blueprint Medicines Appoints Jeffrey Albers As Chief Executive Officer 7/24/2014 8:13:41 AM
Blueprint Medicines To Present At JMP Securities Healthcare Conference 6/20/2014 8:20:47 AM
Blueprint Medicines Presents Positive Data On First Selective FGFR4 Inhibitor 4/7/2014 9:22:08 AM
Blueprint Medicines To Present On The First Isoform Selective FGFR4 Inhibitor At The American Association for Cancer Research Annual Meeting 2014 3/25/2014 9:12:37 AM
12